Mesoblast acquires Osiris’ culture expanded stem cell business for $50M plus another $50M bonus for regulatory milestones

MESOBLAST ACQUIRES OSIRIS' CULTURE EXPANDED STEM CELL THERAPEUTIC BUSINESS (press release) MELBOURNE, Australia and NEW YORK, Oct. 10, 2013 (GLOBE NEWSWIRE) […]


Get access to full posts, newsletters, trends, and market reports for only subscribe for $1/day.